
Horse therapy program brings joy to kids with learning disabilities in Namibia
De Meyer runs a program in the southern African country of Namibia that harnesses the power but also the gentleness of horses to help children with learning disabilities and conditions like ADHD and autism.
Each weekday morning, de Meyer's dusty paddock just outside the capital, Windhoek, is enlivened by a group of eight to 10 children from one of the special schools she helps. The children ride the horses, groom them, stroke them and often, de Meyer says, talk to them.
Merci who participates in the 'Enabling Through the Horse', therapy program, petting one of the animals horse.
De Meyer grew up on a farm surrounded by horses and they've always been part of her life. She said they have a quality that is invaluable: They don't judge the children, no matter how different they are.
'The horse is the hero in this whole situation because these kids don't want to be around a lot of people,' de Meyer said.
De Meyer's program, 'Enabling Through the Horse', is supported by the Namibian Equestrian Federation and won an award last year from the International Equestrian Federation because it 'underlines the wonderful characteristics of the horse in exuding sensitivity and intuition'.
Horse therapy has been promoted by autism groups and those that work with children with learning disabilities as having a positive impact. And animal therapy in general has been found to be useful in many instances, like dogs that help military veterans with post-traumatic stress disorder and therapy cats that are taken to hospitals and nursing homes.
Program founder De Meyer (in red) grew up on a farm surrounded by horses.
Some survivors of the devastating 2023 Hawaii wildfires in the United States found relief in horse therapy while grieving loved ones they had lost.
De Meyer jokes she has 'two-and-a-half horses'. These include two Arabians – a white mare named Faranah and a brown gelding, Lansha – while the 'half' is a miniature horse called Bonzi, who is about head-high for a five-year-old.
The Arabians are often the most useful for the children's therapy because of their size, de Meyer said.
'It gives them self-esteem. When they stroke the horse, the therapy starts because this is a very big animal compared to their height, and they are not scared to stroke the horse ... and then to ride it and tell the horse what they want,' she said.
De Meyer works with children with a range of conditions or disabilities, including autism, attention-deficit/hyperactivity disorder, Down syndrome, those who are non-verbal or touch sensitive, and some who were born with fetal alcohol syndrome and have developmental problems.
She has received interest from other countries in Africa and Asia to start similar programs there.
'The changes that I've seen with the learners are significant,' said Chriszell Louw, a teacher at Dagbreek School, which says it is one of just two government schools in Namibia for children with intellectual disabilities.
'We have a learner that likes to talk a lot. When we come here, she knows she has to keep quiet. She sits in her place.'
'Some of them you see they are more open, they are happy. Some of them were very scared when they started with the horse riding but now they are very excited. When they hear we're going to the horses they are very excited and just want to go by themselves,' Louw said.
De Meyer said her program helps with fine-motor skills, gross-motor skills, muscle strengthening, coordination, balance and posture, all important for kids who struggle to sit at a desk at school and learn.
One simple exercise de Meyer has children do when they ride is to let go of the reins and stretch their arms out straight and to the sides, using only their torso and lower body to balance as a groom leads the horse around the paddock.
Some of the kids break out in smiles when they let go and look like they're soaring.
'We make the world different for these kids,' de Meyer said. – AP
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Star
a day ago
- The Star
Africa CDC warns of widespread drug resistance across Africa
ADDIS ABABA, July 24 (Xinhua) -- The Africa Centers for Disease Control and Prevention (Africa CDC) has warned of widespread drug resistance on the continent, threatening to reverse decades of health and development gains. The Africa CDC, in its latest study titled "Mapping Antimicrobial Resistance and Antimicrobial Use Partnership," released Wednesday, said the "alarming rate" of antimicrobial resistance across 14 African countries poses an urgent continental public health threat. The study, the largest of its kind conducted in Africa, analyzed more than 187,000 test results from 205 laboratories between 2016 and 2019 in 14 countries, including Ethiopia, Ghana, Kenya, Malawi, Mali, and Nigeria, revealing a growing ineffectiveness of antibiotics against common bacterial infections. Drug resistance occurs when bacteria change in ways that make antibiotics used to treat infections less effective. The phenomenon results in common infections becoming harder to treat, more expensive to manage, and more likely to spread, according to the study. It highlighted drug resistance as a growing epidemic affecting multiple countries across the continent. One of the "most concerning" findings is that resistance to a powerful group of antibiotics, known as third-generation cephalosporins, is exceptionally high in Ghana and Malawi. The study also revealed demographic disparities in drug-resistant infections, with older adults and hospitalized patients being particularly vulnerable. It said the existing demographic disparities underscore the need for targeted interventions to protect at-risk populations. The Africa CDC also highlighted "serious gaps" in laboratory infrastructure and data collection systems. Findings reveal that fewer than 2 percent of health facilities were equipped to test for bacterial infections, and only 12 percent of drug resistance records were linked to patient information.


The Star
2 days ago
- The Star
First malaria drug for infants receives Swiss approval
A mother and her child sitting on a bed covered with a mosquito net to protect against malaria-carrying mosquitoes near the town of Bagamoyo in Tanzania. The African nation is one of eight that is expediting approval of the first malaria drug for infants weighing less than 4.5kg. — AFP filepic The first malaria treatment for newborns and young infants has received approval from Swiss health regulators, with eight African countries poised to roll the drug out rapidly, Swiss pharmaceutical giant Novartis announced on July 8 (2025). Malaria is a major killer in Africa, with the continent accounting for 95% of the 597,000 deaths from the disease worldwide in 2023, according to the World Health Organization (WHO). Of those deaths, about 76% – more than 432,000 – were children under five years old, according to the WHO. The infant version of the combined drugs artemether and lumefantrine was developed by Novartis in collaboration with the Medicines for Malaria Venture (MMV), a Geneva-based organisation specialising in research and development of medicines against the disease. 'Until now, there has been no approved malaria treatment for infants weighing less than 4.5kg,' Novartis said in a statement. The approval from Switzerland's health authority is for a dose designed for babies weighing two to five kilogrammes. Eight of the countries hit hardest by malaria – Burkina Faso, Ivory Coast, Kenya, Malawi, Mozambique, Nigeria, Tanzania and Uganda – participated in the Swiss approval process. The countries are now expected to approve the treatment quickly themselves, under a programme to facilitate access to medicines for low- and middle-income countries, Novartis said. The pharmaceutical company said it would introduce the treatment 'on a largely not-for-profit basis' to increase access in places where the mosquito-borne disease is endemic. An estimated 263 million people worldwide had malaria in 2023, according to the WHO. Funding to fight the disease is under threat after US President Donald Trump's moves to cut foreign aid. The US government previously provided around 40% of annual funding globally for control and research into malaria. – AFP

Barnama
3 days ago
- Barnama
No New ASF Cases In Perak, Pig Farms Continue Operations
IPOH, July 22 (Bernama) -- The Perak government has confirmed that no new cases of African swine fever (ASF) have been reported since 2024, indicating that the situation remains under control despite a spike in infections in neighbouring Penang. State Human Resources, Health, Indian Community Affairs and National Integration Committee chairman A. Sivanesan said all pig farms in the state remain operational, noting that pork remains a vital source of protein for the country's non-Muslim population. 'About 26 per cent of the population, roughly eight million people, rely on pork as an alternative protein source. If farms are shut down, these consumers will turn to chicken and fish, which could strain those markets,' he said. ASF was first detected in Perak in wild boars in December 2021, followed by cases at a pig farm in Batang Padang in March 2022 and at the Multi Agriculture farm in Tronoh in October 2023. Between 2022 and 2023, the disease affected 18 farms and 19,335 pigs. Thirteen of those farms have since resumed operations, while five were permanently closed. In 2024, Perak produced 17.4 million kilograms of pork, enough to meet local demand despite ongoing farm restructuring. However, with continued interstate exports, the state still imports pork to meet overall consumption needs. To modernise the sector, Sivanesan will leave for China tomorrow to study advanced pig farming practices. He added that nearly 55 per cent of applications for modern farm planning approval have been approved by local authorities and are currently being processed. On another note, Sivanesan said Perak has recorded only one pertussis (whooping cough) case this year, a two-month-old infant who tested positive after receiving a single dose of the diphtheria-tetanus-pertussis (DTP) vaccine. This represents a 96.6 per cent decline from the 29 cases reported during the same period in 2024. The infant has since made a full recovery and four close contacts tested negative. No deaths have been reported.